| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | EH domain binding | 7.04e-05 | 2 | 168 | 2 | GO:1990175 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DOCK1 TBC1D9B DOCK11 ASAP3 RGPD1 TBC1D9 GNA13 RABGAP1L RABGEF1 AKAP13 ARHGAP45 AGAP1 AGAP3 SOS2 | 1.02e-04 | 507 | 168 | 14 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DOCK1 TBC1D9B DOCK11 ASAP3 RGPD1 TBC1D9 GNA13 RABGAP1L RABGEF1 AKAP13 ARHGAP45 AGAP1 AGAP3 SOS2 | 1.02e-04 | 507 | 168 | 14 | GO:0030695 |
| Domain | VWFA | 9.33e-05 | 82 | 167 | 6 | PS50234 | |
| Domain | VWA | 1.07e-04 | 84 | 167 | 6 | SM00327 | |
| Domain | VWF_A | 2.63e-04 | 99 | 167 | 6 | IPR002035 | |
| Domain | ZF_DAG_PE_1 | 2.68e-04 | 64 | 167 | 5 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 2.68e-04 | 64 | 167 | 5 | PS50081 | |
| Domain | C1 | 2.88e-04 | 65 | 167 | 5 | SM00109 | |
| Domain | PE/DAG-bd | 3.10e-04 | 66 | 167 | 5 | IPR002219 | |
| Domain | FN3 | 4.31e-04 | 199 | 167 | 8 | PS50853 | |
| Domain | G8_domain | 4.71e-04 | 4 | 167 | 2 | IPR019316 | |
| Domain | G8 | 4.71e-04 | 4 | 167 | 2 | PS51484 | |
| Domain | Alpha_catenin | 4.71e-04 | 4 | 167 | 2 | IPR001033 | |
| Domain | Clathrin_a/coatomer_app_sub_C | 4.71e-04 | 4 | 167 | 2 | IPR015873 | |
| Domain | G8 | 4.71e-04 | 4 | 167 | 2 | SM01225 | |
| Domain | VINCULIN_1 | 4.71e-04 | 4 | 167 | 2 | PS00663 | |
| Domain | G8 | 4.71e-04 | 4 | 167 | 2 | PF10162 | |
| Domain | Vinculin_CS | 4.71e-04 | 4 | 167 | 2 | IPR000633 | |
| Domain | - | 4.71e-04 | 4 | 167 | 2 | 3.30.310.30 | |
| Domain | FN3_dom | 5.96e-04 | 209 | 167 | 8 | IPR003961 | |
| Domain | Flavin_mOase | 7.81e-04 | 5 | 167 | 2 | IPR000960 | |
| Domain | Vinculin | 7.81e-04 | 5 | 167 | 2 | PF01044 | |
| Domain | DiMe-aniline_mOase | 7.81e-04 | 5 | 167 | 2 | IPR012143 | |
| Domain | FMO-like | 7.81e-04 | 5 | 167 | 2 | PF00743 | |
| Domain | Flavin_mOase-like | 7.81e-04 | 5 | 167 | 2 | IPR020946 | |
| Domain | DAG/PE-bd | 8.30e-04 | 21 | 167 | 3 | IPR020454 | |
| Domain | ARM-type_fold | DOCK1 MROH9 DOCK11 RANBP6 TOGARAM1 COPG2 FMNL2 AP2A2 USP35 DAAM1 | 9.72e-04 | 339 | 167 | 10 | IPR016024 |
| Domain | PH | 1.08e-03 | 229 | 167 | 8 | PF00169 | |
| Domain | PbH1 | 1.16e-03 | 6 | 167 | 2 | SM00710 | |
| Domain | PbH1 | 1.16e-03 | 6 | 167 | 2 | IPR006626 | |
| Domain | EGF | 1.27e-03 | 235 | 167 | 8 | SM00181 | |
| Domain | IGc2 | 1.27e-03 | 235 | 167 | 8 | SM00408 | |
| Domain | Ig_sub2 | 1.27e-03 | 235 | 167 | 8 | IPR003598 | |
| Domain | FN3 | 1.40e-03 | 185 | 167 | 7 | SM00060 | |
| Domain | VWA | 1.58e-03 | 56 | 167 | 4 | PF00092 | |
| Domain | PH_dom-like | PRKD2 DOCK11 ASAP3 RGPD1 CDC42BPB RABGAP1L AKAP13 PLCB2 AGAP1 AGAP3 SOS2 | 1.60e-03 | 426 | 167 | 11 | IPR011993 |
| Domain | STAT_TF_DNA-bd_sub | 1.62e-03 | 7 | 167 | 2 | IPR012345 | |
| Domain | STAT | 1.62e-03 | 7 | 167 | 2 | IPR001217 | |
| Domain | Vinculin/catenin | 1.62e-03 | 7 | 167 | 2 | IPR006077 | |
| Domain | STAT_int | 1.62e-03 | 7 | 167 | 2 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 1.62e-03 | 7 | 167 | 2 | IPR013801 | |
| Domain | STAT_bind | 1.62e-03 | 7 | 167 | 2 | PF02864 | |
| Domain | STAT_int | 1.62e-03 | 7 | 167 | 2 | PF02865 | |
| Domain | - | 1.62e-03 | 7 | 167 | 2 | 1.10.532.10 | |
| Domain | STAT_alpha | 1.62e-03 | 7 | 167 | 2 | PF01017 | |
| Domain | - | 1.62e-03 | 7 | 167 | 2 | 1.20.1050.20 | |
| Domain | STAT_TF_prot_interaction | 1.62e-03 | 7 | 167 | 2 | IPR013799 | |
| Domain | STAT_TF_coiled-coil | 1.62e-03 | 7 | 167 | 2 | IPR015988 | |
| Domain | - | 1.62e-03 | 7 | 167 | 2 | 2.60.40.630 | |
| Domain | Ig_I-set | 1.63e-03 | 190 | 167 | 7 | IPR013098 | |
| Domain | I-set | 1.63e-03 | 190 | 167 | 7 | PF07679 | |
| Domain | EGF-like_dom | 1.83e-03 | 249 | 167 | 8 | IPR000742 | |
| Domain | DAD_dom | 2.15e-03 | 8 | 167 | 2 | IPR014767 | |
| Domain | STAT_TF_alpha | 2.15e-03 | 8 | 167 | 2 | IPR013800 | |
| Domain | DAD | 2.15e-03 | 8 | 167 | 2 | PS51231 | |
| Domain | Pectin_lyase_fold/virulence | 2.15e-03 | 8 | 167 | 2 | IPR011050 | |
| Domain | Coatomer/calthrin_app_sub_C | 2.15e-03 | 8 | 167 | 2 | IPR009028 | |
| Domain | ArfGap | 2.16e-03 | 29 | 167 | 3 | SM00105 | |
| Domain | ARFGAP | 2.16e-03 | 29 | 167 | 3 | PS50115 | |
| Domain | ArfGap | 2.16e-03 | 29 | 167 | 3 | PF01412 | |
| Domain | ArfGAP | 2.16e-03 | 29 | 167 | 3 | IPR001164 | |
| Domain | Copine | 2.75e-03 | 9 | 167 | 2 | PF07002 | |
| Domain | Drf_GBD | 2.75e-03 | 9 | 167 | 2 | PF06371 | |
| Domain | Drf_FH3 | 2.75e-03 | 9 | 167 | 2 | PF06367 | |
| Domain | ZU5 | 2.75e-03 | 9 | 167 | 2 | SM00218 | |
| Domain | FH3_dom | 2.75e-03 | 9 | 167 | 2 | IPR010472 | |
| Domain | GTPase-bd | 2.75e-03 | 9 | 167 | 2 | IPR010473 | |
| Domain | Copine | 2.75e-03 | 9 | 167 | 2 | IPR010734 | |
| Domain | Drf_FH3 | 2.75e-03 | 9 | 167 | 2 | SM01139 | |
| Domain | Drf_GBD | 2.75e-03 | 9 | 167 | 2 | SM01140 | |
| Domain | - | PRKD2 DOCK11 ASAP3 RGPD1 CDC42BPB RABGAP1L AKAP13 AGAP1 AGAP3 SOS2 | 2.78e-03 | 391 | 167 | 10 | 2.30.29.30 |
| Domain | Death | 3.15e-03 | 33 | 167 | 3 | PF00531 | |
| Domain | fn3 | 3.39e-03 | 162 | 167 | 6 | PF00041 | |
| Domain | ZU5 | 3.41e-03 | 10 | 167 | 2 | PS51145 | |
| Domain | GPS | 3.43e-03 | 34 | 167 | 3 | SM00303 | |
| Domain | PH | 3.61e-03 | 278 | 167 | 8 | SM00233 | |
| Domain | PH_DOMAIN | 3.68e-03 | 279 | 167 | 8 | PS50003 | |
| Domain | GPS | 3.72e-03 | 35 | 167 | 3 | PF01825 | |
| Domain | PH_domain | 3.76e-03 | 280 | 167 | 8 | IPR001849 | |
| Domain | GPS | 4.04e-03 | 36 | 167 | 3 | PS50221 | |
| Domain | GBD/FH3_dom | 4.15e-03 | 11 | 167 | 2 | IPR014768 | |
| Domain | GBD_FH3 | 4.15e-03 | 11 | 167 | 2 | PS51232 | |
| Domain | DHR-1_domain | 4.15e-03 | 11 | 167 | 2 | IPR027007 | |
| Domain | DHR_2 | 4.15e-03 | 11 | 167 | 2 | PS51651 | |
| Domain | DHR_1 | 4.15e-03 | 11 | 167 | 2 | PS51650 | |
| Domain | DHR-2 | 4.15e-03 | 11 | 167 | 2 | PF06920 | |
| Domain | DOCK | 4.15e-03 | 11 | 167 | 2 | IPR026791 | |
| Domain | DOCK_C | 4.15e-03 | 11 | 167 | 2 | IPR010703 | |
| Domain | DOCK-C2 | 4.15e-03 | 11 | 167 | 2 | PF14429 | |
| Domain | DHR-2 | 4.15e-03 | 11 | 167 | 2 | IPR027357 | |
| Domain | GPS | 4.36e-03 | 37 | 167 | 3 | IPR000203 | |
| Domain | Death_domain | 4.71e-03 | 38 | 167 | 3 | IPR000488 | |
| Domain | Coatomer/clathrin_app_Ig-like | 4.95e-03 | 12 | 167 | 2 | IPR013041 | |
| Domain | ZU5 | 4.95e-03 | 12 | 167 | 2 | PF00791 | |
| Domain | ZU5_dom | 4.95e-03 | 12 | 167 | 2 | IPR000906 | |
| Domain | MIRO-like | 5.81e-03 | 13 | 167 | 2 | IPR013684 | |
| Domain | Roc | 5.81e-03 | 13 | 167 | 2 | PF08477 | |
| Domain | - | GP6 CNTN4 LRFN1 TNC MYOM3 OBSL1 PKHD1L1 HEPACAM LRFN5 PKHD1 ASTN1 ROS1 UNC5D | 6.69e-03 | 663 | 167 | 13 | 2.60.40.10 |
| Domain | Cyt_P450_E_grp-I | 7.57e-03 | 45 | 167 | 3 | IPR002401 | |
| Domain | Clathrin/coatomer_adapt-like_N | 7.73e-03 | 15 | 167 | 2 | IPR002553 | |
| Domain | FH2 | 7.73e-03 | 15 | 167 | 2 | PS51444 | |
| Domain | FH2_Formin | 7.73e-03 | 15 | 167 | 2 | IPR015425 | |
| Pubmed | NCOA6 OBSL1 TNRC6B TOGARAM1 CDC42BPB TENM4 AP2A2 SYNJ1 WDR35 PCNT | 2.02e-07 | 225 | 172 | 10 | 12168954 | |
| Pubmed | COL6A1 NUP107 CD2AP LRRC49 RGPD1 IRAK1 TNRC6B LAMC1 COPG2 KIF15 SYNJ1 PCNT | 1.30e-06 | 418 | 172 | 12 | 34709266 | |
| Pubmed | Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5. | 2.35e-06 | 6 | 172 | 3 | 19647226 | |
| Pubmed | A genome-wide association study of acenocoumarol maintenance dosage. | 2.35e-06 | 6 | 172 | 3 | 19578179 | |
| Pubmed | CNTN4 CACNA1E LRFN1 DOCK11 NHSL2 RGPD1 PHB2 TNRC6B CDC42BPB ARPC2 KIF15 AP2A2 SYNJ1 KCNJ1 RABGEF1 CTNNA1 PCNT | 6.51e-06 | 963 | 172 | 17 | 28671696 | |
| Pubmed | NCOA6 differentially regulates the expression of the CYP2C9 and CYP3A4 genes. | 6.54e-06 | 8 | 172 | 3 | 21292004 | |
| Pubmed | The tale of the long tail: the cytoplasmic domain of HIV-1 gp41. | 7.93e-06 | 26 | 172 | 4 | 23077317 | |
| Pubmed | CACNA1E TNC PHB2 KIAA1549 CDC42BPB ARPC2 GRIP1 CTNNA3 GABBR1 AGAP1 AGAP3 | 1.08e-05 | 430 | 172 | 11 | 32581705 | |
| Pubmed | 1.43e-05 | 30 | 172 | 4 | 20529763 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 23151802 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 26999798 | ||
| Pubmed | A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions. | 2.43e-05 | 2 | 172 | 2 | 31443474 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 12377952 | ||
| Pubmed | A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. | 2.43e-05 | 2 | 172 | 2 | 21127177 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 16289657 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 25552366 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 25470773 | ||
| Pubmed | Constitutively active Stat5A and Stat5B promote adipogenesis. | 2.43e-05 | 2 | 172 | 2 | 21431790 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 28500076 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 21826656 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 7720707 | ||
| Pubmed | STAT5A and STAT5B have opposite correlations with drug response gene expression. | 2.43e-05 | 2 | 172 | 2 | 27264955 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 22159083 | ||
| Pubmed | Gene structure and upstream regulatory regions of human CYP2C9 and CYP2C18. | 2.43e-05 | 2 | 172 | 2 | 8333835 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 20008792 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 33199496 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 19752566 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 16502315 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 12217382 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 31599926 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 10594041 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 21036145 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 10486277 | ||
| Pubmed | Identification of human STAT5-dependent gene regulatory elements based on interspecies homology. | 2.43e-05 | 2 | 172 | 2 | 16840779 | |
| Pubmed | The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells. | 2.43e-05 | 2 | 172 | 2 | 15128421 | |
| Pubmed | STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice. | 2.43e-05 | 2 | 172 | 2 | 30377054 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 23565285 | ||
| Pubmed | Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer. | 2.43e-05 | 2 | 172 | 2 | 32790723 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 18492722 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 10066807 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 10835485 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 35464049 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 18286195 | ||
| Pubmed | Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells. | 2.43e-05 | 2 | 172 | 2 | 23773921 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 8631883 | ||
| Pubmed | Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. | 2.43e-05 | 2 | 172 | 2 | 11030348 | |
| Pubmed | Association between STAT5 polymorphisms and glioblastoma risk in Han Chinese population. | 2.43e-05 | 2 | 172 | 2 | 24878107 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 12847485 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 12835478 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 7568026 | ||
| Pubmed | Identification of STAT5A and STAT5B target genes in human T cells. | 2.43e-05 | 2 | 172 | 2 | 24497979 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 17536022 | ||
| Pubmed | STAT5 transcriptional activity is impaired by LIF in a mammary epithelial cell line. | 2.43e-05 | 2 | 172 | 2 | 17382296 | |
| Pubmed | STAT5 is essential for Akt/p70S6 kinase activity during IL-2-induced lymphocyte proliferation. | 2.43e-05 | 2 | 172 | 2 | 17911616 | |
| Pubmed | STAT5 signaling in sexually dimorphic gene expression and growth patterns. | 2.43e-05 | 2 | 172 | 2 | 10486314 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 17599554 | ||
| Pubmed | MiR-21 is under control of STAT5 but is dispensable for mammary development and lactation. | 2.43e-05 | 2 | 172 | 2 | 24497923 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 24335105 | ||
| Pubmed | Brain STAT5 signaling modulates learning and memory formation. | 2.43e-05 | 2 | 172 | 2 | 29460051 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 31126972 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 28606561 | ||
| Pubmed | Cell intrinsic defects in cytokine responsiveness of STAT5-deficient hematopoietic stem cells. | 2.43e-05 | 2 | 172 | 2 | 12393407 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 11701612 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 12039059 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 21178171 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 9786912 | ||
| Pubmed | Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo. | 2.43e-05 | 2 | 172 | 2 | 20233708 | |
| Pubmed | Involvement of the STAT5 signaling pathway in the regulation of mouse preimplantation development. | 2.43e-05 | 2 | 172 | 2 | 16775227 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 17447893 | ||
| Pubmed | Uterine leiomyoma with RAD51B::NUDT3 fusion: a report of 2 cases. | 2.43e-05 | 2 | 172 | 2 | 37466765 | |
| Pubmed | αE-catenin is an autoinhibited molecule that coactivates vinculin. | 2.43e-05 | 2 | 172 | 2 | 22586082 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 22918969 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 16115927 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 23275557 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 11867689 | ||
| Pubmed | Global analysis of IL-2 target genes: identification of chromosomal clusters of expressed genes. | 2.43e-05 | 2 | 172 | 2 | 15980098 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 27426949 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 15340066 | ||
| Pubmed | STAT5A/B gene locus undergoes amplification during human prostate cancer progression. | 2.43e-05 | 2 | 172 | 2 | 23660011 | |
| Pubmed | Role of Stat5 in type I interferon-signaling and transcriptional regulation. | 2.43e-05 | 2 | 172 | 2 | 12901872 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 28074064 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 36755813 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 25333863 | ||
| Pubmed | A role for STAT5 in the pathogenesis of IL-2-induced glucocorticoid resistance. | 2.43e-05 | 2 | 172 | 2 | 12421978 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 9852045 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 19966185 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 21704724 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 38618957 | ||
| Pubmed | Characterization and cloning of STAT5 from IM-9 cells and its activation by growth hormone. | 2.43e-05 | 2 | 172 | 2 | 8732682 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 26717567 | ||
| Pubmed | The neonatal microenvironment programs innate γδ T cells through the transcription factor STAT5. | 2.43e-05 | 2 | 172 | 2 | 32281944 | |
| Pubmed | Adipocyte STAT5 deficiency does not affect blood glucose homeostasis in obese mice. | 2.43e-05 | 2 | 172 | 2 | 34818373 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 23465551 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 11756158 | ||
| Pubmed | Regulation of IL-1 receptor-associated kinases by lipopolysaccharide. | 2.43e-05 | 2 | 172 | 2 | 11937546 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 29203513 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 27367207 | ||
| Pubmed | Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation. | 2.43e-05 | 2 | 172 | 2 | 16493008 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 8816482 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 10851057 | ||
| Cytoband | 1q24.3 | 5.62e-05 | 20 | 172 | 3 | 1q24.3 | |
| Cytoband | 11p14.2 | 2.89e-04 | 7 | 172 | 2 | 11p14.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q21 | 5.03e-04 | 97 | 172 | 4 | chr14q21 | |
| GeneFamily | Fibronectin type III domain containing | 7.34e-05 | 160 | 115 | 7 | 555 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 1.60e-04 | 17 | 115 | 3 | 1291 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.49e-04 | 206 | 115 | 7 | 682 | |
| GeneFamily | Ankyrin repeat domain containing|Death associated protein kinases | 3.96e-04 | 5 | 115 | 2 | 1021 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 5.75e-04 | 161 | 115 | 6 | 593 | |
| GeneFamily | ArfGAPs | 1.19e-03 | 33 | 115 | 3 | 395 | |
| GeneFamily | Copines | 1.40e-03 | 9 | 115 | 2 | 829 | |
| GeneFamily | WD repeat domain containing|GRAM domain containing|BEACH domain containing | 2.99e-03 | 13 | 115 | 2 | 1146 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CNTN4 CACNA1E FBLL1 ANK1 PCLO LRRC49 KIAA1549 GRID2 XK FMNL2 TBC1D9 GRIP1 FSIP2 SYNJ1 LRFN5 RABGAP1L CYP4X1 PRKCZ DAAM1 CCDC144A AGAP1 | 1.27e-05 | 1106 | 172 | 21 | M39071 |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | PPP1R21 CNTN4 PCLO TNRC6B RABGAP1L PKHD1 AKAP13 SLC5A12 AGAP1 | 1.64e-05 | 221 | 172 | 9 | M39222 |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | PPP1R21 CNTN4 SLC26A3 ANK1 KIAA1549 TNRC6B ADAMTS8 TENM4 CTNNA3 PIP5K1A AKAP13 SLC5A12 | 2.15e-05 | 417 | 172 | 12 | M39224 |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | DOCK1 RAD51B SLC26A3 TNRC6B EXT1 FMNL2 WDPCP GRIP1 RABGAP1L AGAP1 | 5.87e-09 | 199 | 172 | 10 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.78e-08 | 181 | 172 | 9 | 071f9bb5d39070cdc473d9b0e094d196bc702b56 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.15e-08 | 183 | 172 | 9 | 738e94b50c4c08c727d4eed0708dda08aa6891b4 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.35e-08 | 184 | 172 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.35e-08 | 184 | 172 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.35e-08 | 184 | 172 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.78e-08 | 186 | 172 | 9 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 3.06e-07 | 168 | 172 | 8 | 8697b40b2ec2cce68ef3beb4792eb3eff29be053 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.56e-07 | 177 | 172 | 8 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 6.91e-07 | 187 | 172 | 8 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.19e-07 | 188 | 172 | 8 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.19e-07 | 188 | 172 | 8 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.19e-07 | 188 | 172 | 8 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.48e-07 | 189 | 172 | 8 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.79e-07 | 190 | 172 | 8 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 8.43e-07 | 192 | 172 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-06 | 198 | 172 | 8 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-06 | 198 | 172 | 8 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 2.55e-06 | 156 | 172 | 7 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 2.66e-06 | 157 | 172 | 7 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.27e-06 | 162 | 172 | 7 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.65e-06 | 176 | 172 | 7 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.86e-06 | 177 | 172 | 7 | f902600c639087664316b3cf30cab243bc3d1c5c | |
| ToppCell | Adult-Epithelial-club_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.86e-06 | 177 | 172 | 7 | d652b7d84fe6aa38319d8d5adc72c70441bd0088 | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.08e-06 | 178 | 172 | 7 | 23a12d3d971b857d5be8e907334d1f6b49eeeb32 | |
| ToppCell | Adult-Epithelial-club_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.08e-06 | 178 | 172 | 7 | 35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.31e-06 | 179 | 172 | 7 | 8766a5a066091879f521acfc612abf563ff78808 | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.54e-06 | 180 | 172 | 7 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.54e-06 | 180 | 172 | 7 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 6.78e-06 | 181 | 172 | 7 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.29e-06 | 183 | 172 | 7 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 7.55e-06 | 184 | 172 | 7 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.55e-06 | 184 | 172 | 7 | da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.82e-06 | 185 | 172 | 7 | 3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.10e-06 | 186 | 172 | 7 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.39e-06 | 187 | 172 | 7 | db2974e2e87ac9f1c2407a371d5ed89af09fc9b7 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 8.39e-06 | 187 | 172 | 7 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.39e-06 | 187 | 172 | 7 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.99e-06 | 189 | 172 | 7 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.99e-06 | 189 | 172 | 7 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.63e-06 | 191 | 172 | 7 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.63e-06 | 191 | 172 | 7 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 9.96e-06 | 192 | 172 | 7 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-05 | 193 | 172 | 7 | ffa1932da2979d7b63dbac32eb5788346a3f5b2a | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 1.03e-05 | 193 | 172 | 7 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.03e-05 | 193 | 172 | 7 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.03e-05 | 193 | 172 | 7 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.03e-05 | 193 | 172 | 7 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.07e-05 | 194 | 172 | 7 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.10e-05 | 195 | 172 | 7 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-05 | 195 | 172 | 7 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.14e-05 | 196 | 172 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_only / Treatment groups by lineage, cell group, cell type | 1.22e-05 | 198 | 172 | 7 | d205dfcfe1f20e1e21bf84759e723d9e6e610a5c | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-05 | 198 | 172 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.22e-05 | 198 | 172 | 7 | 6ba5e5970109a04ed968bac7ff099ae250c579dc | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | 1.26e-05 | 199 | 172 | 7 | f09b40245d3d826275bbe5f508dedccc75a911bd | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | 1.26e-05 | 199 | 172 | 7 | e45448ec4db8875c8aaa9aad109a10e2905a4226 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 137 | 172 | 6 | 0aa4e14b32da0cda677cc0ed6ae470f6ecd77bea | |
| ToppCell | COVID-19_Mild|World / 5 Neutrophil clusters in COVID-19 patients | 2.80e-05 | 152 | 172 | 6 | 2ff0980dfd8d430cca14649151d856edef115720 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-05 | 153 | 172 | 6 | d6526d17826470534b766df144c74e73eb83fdad | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-05 | 160 | 172 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-05 | 160 | 172 | 6 | 41d6c811c445c0ba9b6a2deb10a3b6b793172582 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-05 | 160 | 172 | 6 | c1d03c0ac9c12615a06499209fcdf18e9b6f1fba | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-05 | 160 | 172 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.13e-05 | 163 | 172 | 6 | 1e8ab00ecc2d2ba35aa6745c0ed38663e26312e8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.13e-05 | 163 | 172 | 6 | 431221a41d396b09170476179590eaf8a55266d8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.23e-05 | 170 | 172 | 6 | 5d5f208682be21ed58320f5fc083a7898f8712da | |
| ToppCell | Control-Epithelial_cells-Airway_basal|Control / group, cell type (main and fine annotations) | 5.40e-05 | 171 | 172 | 6 | 3965ced4be6db14265a90673502fceee425837ca | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.76e-05 | 173 | 172 | 6 | 9f892d756d05e573af018db64edb130ff187ad47 | |
| ToppCell | COVID-19-lung-RBC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.14e-05 | 175 | 172 | 6 | 4c35292ad2ac712ba7516f27dd6eac6ba8fdd163 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 175 | 172 | 6 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.33e-05 | 176 | 172 | 6 | 052b54c4337ca728974a106b6dbd3b72dd28eb23 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.33e-05 | 176 | 172 | 6 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.54e-05 | 177 | 172 | 6 | ac8f774596068e66c0a9ea8a318be0ce5f5df834 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.54e-05 | 177 | 172 | 6 | c9e8149639551a4c8daa90fcb2b895fdcff2e2ba | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.54e-05 | 177 | 172 | 6 | d9c4a93b0e04a13bf39992dd1c1ec8df2c5f89fe | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.54e-05 | 177 | 172 | 6 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-05 | 178 | 172 | 6 | c20f050344a2e120e685e2a7fe36c6dfc1dc37b6 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.74e-05 | 178 | 172 | 6 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-05 | 178 | 172 | 6 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.95e-05 | 179 | 172 | 6 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.95e-05 | 179 | 172 | 6 | 58ae5a97fe2a14e1c6fdeb886397eb06fdaf0428 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-05 | 179 | 172 | 6 | 4166c4e1a8748a79ac6a11fd0b97c5344be2321b | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.95e-05 | 179 | 172 | 6 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.39e-05 | 181 | 172 | 6 | 9542c19edc9bd2cba68c01c2a8407705398e3011 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.39e-05 | 181 | 172 | 6 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.39e-05 | 181 | 172 | 6 | 8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.39e-05 | 181 | 172 | 6 | 6980ea624151da32b7f537f263e40fcb87a02e81 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.39e-05 | 181 | 172 | 6 | 57994ff4ecffb15653aee00644d9f887f5e3461d | |
| ToppCell | Posterior_cortex-Macroglia-ASTROCYTE-Gja1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.43e-05 | 112 | 172 | 5 | e30cd0b7b755c63081bbeed4e1a884b6640d34f8 | |
| ToppCell | Posterior_cortex-Macroglia-ASTROCYTE|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.43e-05 | 112 | 172 | 5 | 1c0bcc6c972c50a9d950cd56b65efb8d778ec25a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.62e-05 | 182 | 172 | 6 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.62e-05 | 182 | 172 | 6 | 9d67717a6e13bcb54c1297a3e4e3abf4e51628a3 | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.86e-05 | 183 | 172 | 6 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.86e-05 | 183 | 172 | 6 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.10e-05 | 184 | 172 | 6 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-5_PVALB_TRIM67|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.10e-05 | 184 | 172 | 6 | 7f6c8912677764d438ab0555faca344d74c2f483 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.10e-05 | 184 | 172 | 6 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 8.34e-05 | 185 | 172 | 6 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.34e-05 | 185 | 172 | 6 | 1bbc2ba8a20f72f61981b1301cdd6018cdd9150d | |
| Disease | cortical thickness | RAD51B STK17B LRRC49 TNRC6B LAMC1 EXT1 ADAMTS8 TSC22D2 FMNL2 ARPC2 GRIP1 CELSR1 GNA13 PKHD1 PRKCZ USP35 AGAP1 AGAP3 SOS2 | 1.91e-05 | 1113 | 167 | 19 | EFO_0004840 |
| Disease | intraocular pressure measurement | RAD51B MROH9 COL6A1 PCLO ADAMTS8 TSC22D2 FMNL2 BABAM2 PKHD1 AKAP13 TMEM26 SOS2 | 3.57e-05 | 509 | 167 | 12 | EFO_0004695 |
| Disease | X-21258 measurement | 9.52e-05 | 3 | 167 | 2 | EFO_0800802 | |
| Disease | diet measurement, body mass index | 1.89e-04 | 20 | 167 | 3 | EFO_0004340, EFO_0008111 | |
| Disease | nephrotic syndrome type 20 (implicated_via_orthology) | 1.90e-04 | 4 | 167 | 2 | DOID:0070357 (implicated_via_orthology) | |
| Disease | progranulin measurement | 2.53e-04 | 22 | 167 | 3 | EFO_0004625 | |
| Disease | neuroimaging measurement | RAD51B STK17B LRRC49 RGPD1 TNRC6B LAMC1 EXT1 TSC22D2 CELSR1 SYNJ1 GNA13 PKHD1 PRKCZ GABBR1 AGAP1 AGAP3 | 3.95e-04 | 1069 | 167 | 16 | EFO_0004346 |
| Disease | Ciliopathies | 4.15e-04 | 110 | 167 | 5 | C4277690 | |
| Disease | Substance abuse problem | 5.29e-04 | 116 | 167 | 5 | C0740858 | |
| Disease | cortical surface area measurement | RAD51B PRKD2 STK17B RGPD1 TNRC6B LAMC1 EXT1 TSC22D2 FMNL2 GRIP1 CELSR1 PKHD1 PRKCZ USP35 DAAM1 AGAP1 AGAP3 SOS2 | 6.43e-04 | 1345 | 167 | 18 | EFO_0010736 |
| Disease | glycine conjugate of C10H14O2 (1) measurement | 6.56e-04 | 7 | 167 | 2 | EFO_0800655 | |
| Disease | invasive lobular carcinoma (is_marker_for) | 6.56e-04 | 7 | 167 | 2 | DOID:3457 (is_marker_for) | |
| Disease | alcohol consumption measurement | DOCK1 CACNA1E CPNE8 PCLO GCKR FMNL2 BABAM2 WDPCP FAM135B GRIP1 LRFN5 RABGAP1L ASB3 PKHD1 SMU1 WDR90 CTNNA1 | 7.12e-04 | 1242 | 167 | 17 | EFO_0007878 |
| Disease | pneumococcal meningitis | 8.72e-04 | 8 | 167 | 2 | EFO_1001114 | |
| Disease | response to alcohol | 8.80e-04 | 75 | 167 | 4 | EFO_0005526 | |
| Disease | Disproportionate short stature | 9.71e-04 | 77 | 167 | 4 | C0878659 | |
| Disease | serum metabolite measurement | MROH9 CNTN4 CACNA1E CYP2C9 CYP2C18 GPAA1 HYKK GCKR SLC7A6 ITGAM PARP4 RABGAP1L TXNDC16 BBOX1 | 1.01e-03 | 945 | 167 | 14 | EFO_0005653 |
| Disease | cognitive function measurement | RAD51B CNTN4 CACNA1E COPG2 GRID2 EXT1 TSC22D2 SLC7A6 WDPCP FAM135B TENM4 GUCA1A RABGAP1L ASB3 CTNNA3 PKHD1 AGAP1 REV1 | 1.33e-03 | 1434 | 167 | 18 | EFO_0008354 |
| Disease | metabolite measurement | 1.39e-03 | 560 | 167 | 10 | EFO_0004725 | |
| Disease | gamma-glutamylthreonine measurement | 1.39e-03 | 10 | 167 | 2 | EFO_0021143 | |
| Disease | response to bronchodilator, FEV/FEC ratio | CNTN4 HYKK GRID2 GCKR F2RL1 FAM135B GRIP1 TENM4 ASB3 PKHD1 UNC5D AGAP1 | 1.45e-03 | 766 | 167 | 12 | EFO_0004713, GO_0097366 |
| Disease | Moyamoya disease | 1.51e-03 | 40 | 167 | 3 | MONDO_0016820 | |
| Disease | cardiac troponin T measurement | 1.59e-03 | 219 | 167 | 6 | EFO_0005043 | |
| Disease | Uterine leiomyoma | 1.80e-03 | 91 | 167 | 4 | HP_0000131 | |
| Disease | liver fat measurement | 1.86e-03 | 43 | 167 | 3 | EFO_0010821 | |
| Disease | triacylglycerol 56:6 measurement | 1.86e-03 | 43 | 167 | 3 | EFO_0010433 | |
| Disease | RS-6-hydroxywarfarin measurement | 1.93e-03 | 155 | 167 | 5 | EFO_0803328 | |
| Disease | Alzheimer disease, polygenic risk score | RAB23 CACNA1E OR2B2 CD2AP WDPCP FSIP2 CTNNA3 PKHD1 CTNNA1 GABBR1 | 1.94e-03 | 586 | 167 | 10 | EFO_0030082, MONDO_0004975 |
| Disease | unipolar depression, bipolar disorder | 1.99e-03 | 156 | 167 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | Methionine sulfoxide measurement | 2.02e-03 | 12 | 167 | 2 | EFO_0021650 | |
| Disease | niacinamide measurement | 2.02e-03 | 12 | 167 | 2 | EFO_0010511 | |
| Disease | systemic lupus erythematosus | RAD51B RAB23 MROH9 DEAF1 IRAK1 CDH23 LAMC1 ITGAM RABGAP1L CTNNA3 CCDC116 GABBR1 | 2.06e-03 | 799 | 167 | 12 | MONDO_0007915 |
| Disease | brain connectivity measurement | 2.08e-03 | 400 | 167 | 8 | EFO_0005210 | |
| Disease | brain volume measurement | PPP1R21 PRKD2 TBC1D9B STK17A LRRC49 ADAMTS8 CCDC144CP PKHD1 PRKCZ DAAM1 | 2.16e-03 | 595 | 167 | 10 | EFO_0006930 |
| Disease | major depressive episode | 2.40e-03 | 47 | 167 | 3 | EFO_0007634 | |
| Disease | caudate nucleus measurement, functional brain measurement, response to reward | 2.40e-03 | 47 | 167 | 3 | EFO_0007849, EFO_0008387, EFO_0008396 | |
| Disease | serum IgG glycosylation measurement | 3.06e-03 | 523 | 167 | 9 | EFO_0005193 | |
| Disease | monoclonal gammopathy | 3.39e-03 | 53 | 167 | 3 | EFO_0000203 | |
| Disease | 5-oxoproline measurement | 3.63e-03 | 16 | 167 | 2 | EFO_0010988 | |
| Disease | unipolar depression | CACNA1E ABCA13 TNC STK17B PCLO EXT1 CDC42BPB WDPCP FAM135B LRFN5 CTNNA3 PKHD1 ASTN1 DAAM1 GABBR1 | 3.65e-03 | 1206 | 167 | 15 | EFO_0003761 |
| Disease | lymphocyte count | RAD51B CYP2C9 ANK1 OPN3 IRAK1 CDH23 TNRC6B GCKR RRM1 FMNL2 STAT5B TENM4 NUDT3 ASB3 ADGRE1 ARHGAP45 AGAP1 | 4.01e-03 | 1464 | 167 | 17 | EFO_0004587 |
| Disease | mean corpuscular hemoglobin concentration | RAD51B PPP1R21 GPAA1 ANK1 STK17A PHB2 TNRC6B GCKR RRM1 GNA14 ASB3 PIP5K1A AKAP13 AGAP1 | 4.20e-03 | 1105 | 167 | 14 | EFO_0004528 |
| Disease | Drug habituation | 4.20e-03 | 115 | 167 | 4 | C0013170 | |
| Disease | Drug abuse | 4.20e-03 | 115 | 167 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 4.20e-03 | 115 | 167 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 4.20e-03 | 115 | 167 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 4.20e-03 | 115 | 167 | 4 | C0013222 | |
| Disease | Drug Dependence | 4.20e-03 | 115 | 167 | 4 | C1510472 | |
| Disease | Substance Dependence | 4.20e-03 | 115 | 167 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 4.20e-03 | 115 | 167 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 4.20e-03 | 115 | 167 | 4 | C0029231 | |
| Disease | insulin measurement | 4.25e-03 | 267 | 167 | 6 | EFO_0004467 | |
| Disease | C-X-C motif chemokine 16 measurement | 4.59e-03 | 18 | 167 | 2 | EFO_0010911 | |
| Disease | metabolonic lactone sulfate measurement | 5.11e-03 | 19 | 167 | 2 | EFO_0800659 | |
| Disease | Hypertriglyceridemia | 5.11e-03 | 19 | 167 | 2 | EFO_0004211 | |
| Disease | cytomegalovirus virus reactivation, response to allogeneic hematopoietic stem cell transplant | 5.11e-03 | 19 | 167 | 2 | EFO_0007044, EFO_0020106 | |
| Disease | Ulcerative Colitis | 5.51e-03 | 63 | 167 | 3 | C0009324 | |
| Disease | corneal hysteresis | 5.66e-03 | 20 | 167 | 2 | EFO_0010066 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VFVFSLEDEISFQTV | 161 | Q96P47 | |
| SSATEEAEESFEFVV | 561 | Q96P47 | |
| TSAVATLTDSDEKFI | 251 | Q96KC9 | |
| TLTDSDEKFITVFEL | 256 | Q96KC9 | |
| DEKFITVFELTTSAE | 261 | Q96KC9 | |
| SVAEFLAVTAEDLSS | 6 | Q8TDY4 | |
| FLTESQVLDSLETVV | 76 | Q8IYX3 | |
| IFVFSLEDEISFQTV | 141 | Q9UPQ3 | |
| EEETLTFEAAVATSL | 2246 | Q15878 | |
| LVDETATFAVDVLST | 306 | Q8IZF6 | |
| DLEETTTLASFISEV | 286 | Q13790 | |
| ATTLTRETVESDLIF | 671 | Q4VNC1 | |
| SEARFVETLLVADAS | 216 | Q9UP79 | |
| SVTDVLKVVTDETSF | 781 | P16157 | |
| LKVVTDETSFVLVSD | 786 | P16157 | |
| VTVVFSTVFKDDDDV | 161 | O15144 | |
| ETAETFDAVVASEVV | 211 | Q9NZJ6 | |
| SEIADLTFNTVAFTE | 41 | Q9H201 | |
| EVDFRASSISEEVAV | 1356 | Q12802 | |
| ASIFARSLSATDIEV | 806 | Q8IWV2 | |
| FSDILEEIAEFLTSV | 2631 | Q86UQ4 | |
| EEDASEISVSVVFET | 296 | Q8IYA2 | |
| VAAVLSTTKDDVFVF | 1231 | Q9NYQ6 | |
| FDSLTVRTSKETDVV | 461 | Q9Y5K6 | |
| FIFADSLSSVETLLT | 446 | Q96NX9 | |
| SLETLTAAEATAFER | 3311 | Q9H251 | |
| LTEVTDLLVDESSFT | 206 | O75185 | |
| VETETVLSFVDDIIS | 1081 | O14525 | |
| STVASTDILATVLEE | 586 | O94973 | |
| IDTESAFSAERLVEI | 141 | O15315 | |
| VLVFSTTDRESFEAV | 86 | Q9ULC3 | |
| TSIETDRVSKEFIEF | 131 | Q9UJ41 | |
| QSALEEESVFAVTAV | 231 | P57740 | |
| FVSAFLFSIETETTI | 136 | P48544 | |
| LVETFTLFDSSDLQS | 666 | Q9HCM3 | |
| TLISSTAFDDVFALE | 136 | Q96NI6 | |
| ALTALVTVSSEEFED | 341 | Q96K31 | |
| EIDDESASFTVTVTE | 971 | O75147 | |
| ALETIAVAFSSTVSE | 206 | Q92619 | |
| ESRLVEDTFTIDEVS | 41 | Q9NQ48 | |
| VSIDILTSREQFFSD | 621 | Q6P0N0 | |
| ADVDTTQESVFATVA | 76 | Q9NS87 | |
| ELSSDVVTSLDVAVE | 226 | O43292 | |
| TEVFTSTLDDLEERV | 316 | Q9UBS5 | |
| EFVEKTLSTIATSTD | 91 | Q16836 | |
| DISEDEIFTSLTAAR | 66 | Q9H0R4 | |
| ESEVVSTITAIFSLA | 41 | Q9NUN5 | |
| RVESAAFDAFLSTVE | 151 | Q9P244 | |
| ATETILSQELTDFTF | 2316 | Q5CZC0 | |
| FIVNSSVFLEEVISE | 4941 | Q5CZC0 | |
| SIVLEFTTSEILVAD | 4991 | Q5CZC0 | |
| AEFSEATAELTVSFT | 221 | Q9HCN6 | |
| ATAELTVSFTNEVFT | 226 | Q9HCN6 | |
| SFITEVVETNLVAFD | 241 | O43424 | |
| IDSTASAEAVFASEV | 281 | A6NHQ2 | |
| FDAVTTLETTAVLRS | 2456 | Q9Y6V0 | |
| FRSESEEEVLLVSSS | 26 | O95989 | |
| SSLTLESFFQEVELV | 686 | Q96JB1 | |
| SVIEFTETSAVFEDG | 301 | P31512 | |
| VEVVLSASATFEDFQ | 121 | Q9BZL6 | |
| ITTVSFTFIEFDEIV | 441 | Q8IUZ0 | |
| TTTAVISKDFTEDRI | 51 | P53602 | |
| VIFTLDDTVAEFVAA | 311 | P53602 | |
| FTLTISILQSEDFAV | 91 | A0A087WSY6 | |
| FSFSEDSVTVEVTAR | 636 | Q32M88 | |
| TSILFLVSSSEFDQV | 241 | Q14344 | |
| DDEFSVSSVLASDVI | 1151 | Q9Y5S2 | |
| TASVTTDFEDDEFVV | 536 | Q9UKK3 | |
| LFESITEDTVTVLET | 321 | Q6ZMI0 | |
| LAVDTDTFSFGVVVL | 401 | P51617 | |
| EDTVIVLIFLTEVSF | 521 | Q5TGP6 | |
| SLILDDVAITELSFS | 176 | Q99623 | |
| VEDFITTSFDSQETL | 2311 | O95613 | |
| TSTTLEKLEVAESEF | 546 | Q99755 | |
| SDSTVAEVTSIQLEF | 391 | Q9UKM7 | |
| SDVFTFSVSLEVKED | 271 | Q5R372 | |
| EFVLVSFSALSTELQ | 11 | Q9H209 | |
| ADTSVFELEALTATV | 191 | Q9H209 | |
| CSAVSDFDFIVTIVV | 471 | O43422 | |
| EVNTTFEDFVAIISS | 691 | O75400 | |
| TEIDTVVFIFTLDDN | 401 | Q14397 | |
| DTKSDSILEDSTIFV | 36 | Q14686 | |
| ETVFSVDEFSASVLT | 56 | P55085 | |
| IIFIITSDESLSVDD | 371 | Q9H1Y3 | |
| AVDDITSIDDFLAVS | 496 | Q9UI47 | |
| FITVASFSFSDVEDL | 931 | Q9Y4D1 | |
| SDTISDALLTDSFII | 161 | O95876 | |
| SFVTDIFERIASEAS | 66 | Q96A08 | |
| SVSIDTLIFTLEFTN | 416 | Q9Y575 | |
| TFSEEQASALVESVF | 16 | A2RU49 | |
| FIDIVFIVDSSESSK | 46 | Q2UY09 | |
| ATEVSLTVLDTISFF | 1401 | Q5JSL3 | |
| SESETFDTLVFDALV | 666 | Q14185 | |
| AVDDITSIDDFLAVS | 501 | P35221 | |
| EDTVLSTTEVDFAFT | 566 | Q16394 | |
| ALLSVSFEDTEATQV | 201 | Q9NXR7 | |
| VDLFFVLDTSESVAL | 36 | P12109 | |
| ALTFDRASTVEATAV | 346 | O75398 | |
| TLLSFSVDSEFTFVD | 276 | Q8IYJ1 | |
| FSDIDVHSEVSTFLL | 301 | Q8N118 | |
| ILSSTFVDFTDIGVD | 251 | O75936 | |
| EEDASEISVSVVFET | 346 | Q3MJ40 | |
| IITDTEISEFDVTKS | 341 | P24588 | |
| ATTALRTFLEATLED | 266 | A2IDD5 | |
| SFVSEISDEFKVVVV | 366 | Q9UBF2 | |
| AVTFDFESVESTVES | 146 | Q96PY5 | |
| DILTFTIALTASEVI | 206 | Q8N6I1 | |
| TAEEFTDTVFSKIDV | 131 | P43080 | |
| FSVILDFVESFDVET | 221 | O00187 | |
| STVKELTETSAIFED | 301 | Q99518 | |
| LTETSAIFEDGTVEE | 306 | Q99518 | |
| LVASTTVLELSEAFT | 151 | Q14CZ8 | |
| FTLTISSLQSEDFAV | 91 | P01624 | |
| TSTKAEAERTFAEVT | 1441 | P11047 | |
| VTVTFSDFQDSDLIA | 556 | P01042 | |
| EFTVESLIATVTDMF | 281 | P33260 | |
| EFTIESLENTAVDLF | 281 | P11712 | |
| VDFESVSSVTALEAL | 21 | Q9NQM4 | |
| SAETFTLDSLKAVEV | 1016 | Q49AJ0 | |
| EEDASEISVSVVFET | 346 | A2RUR9 | |
| DSSITSKVTLEIEFD | 546 | Q9Y3R0 | |
| TLLSFLVETEVSFLD | 286 | Q86YQ8 | |
| EFVISLAEKNTTFDT | 51 | Q14562 | |
| DTTANEAELFFISVL | 191 | Q9GZK3 | |
| EDAVTAFESIKSVVS | 656 | P0DJD0 | |
| DTTFNEAELFVASVV | 191 | Q5TZ20 | |
| FESVTSIIFLVALSE | 216 | O95837 | |
| FSILEEEISAFLISS | 501 | Q92521 | |
| FTRTLSDIVSKEDFV | 161 | Q8NEY4 | |
| FVGTAADILEFTSET | 181 | Q6ZUK4 | |
| ISFSRIAETELESTV | 1066 | Q07890 | |
| TEDVSSEIFDVSRAT | 41 | O75157 | |
| QESEVFRVTSTEFIS | 91 | O43426 | |
| DDVFVASRTTEDLFT | 1101 | Q5HYW2 | |
| EETFSSVSQLATDFI | 256 | O94768 | |
| STELSLLADEVITVF | 321 | Q9Y371 | |
| SEASVLTVADLADLF | 1661 | Q149N8 | |
| TDIISALVTSTFIIE | 321 | P51692 | |
| ISISQSDDILTFAVA | 1661 | P08F94 | |
| LDFSAVSFLDVSSVR | 651 | P40879 | |
| IVSTAEILFNDSVFT | 1066 | P11215 | |
| VTTIASVADTIEEKF | 521 | O60518 | |
| FAFLETIVTAVTDEF | 401 | Q99884 | |
| EFDVLSESAVDFIRT | 286 | Q9UEE5 | |
| TDIISALVTSTFIIE | 321 | P42229 | |
| QTLSIFDSEEDITTF | 96 | Q66K14 | |
| EETSSLATVFLESVE | 396 | Q14246 | |
| STAVETDFGLLVTFD | 426 | O75443 | |
| LFTATVTDFLAIDAV | 191 | Q9H3T3 | |
| DSSSVIEIDFLRSDI | 71 | O43829 | |
| AVASEITVFLFLSDA | 26 | Q6XE38 | |
| ELTVELTEETFNATV | 391 | Q9P2K2 | |
| VLDGAVVSASFDDSV | 1391 | Q96KV7 | |
| LALVSFEDVVVTFTG | 6 | Q96NL3 | |
| ESVTFEDVAVTFTQE | 11 | Q14592 | |
| AFFTTAETLTDIVLS | 46 | Q9BRK0 | |
| VSLNTVDSIESFVAD | 36 | Q2TAY7 | |
| EVFRAAVDLEISSAS | 871 | Q9UBZ9 | |
| VTTVELDTLAAETAA | 51 | P23921 | |
| VSSREEAFTDLSLAF | 586 | Q9P2H5 | |
| IVTETSFTIDELEEL | 816 | Q6ZT07 | |
| TEEEIALFSSAVLIS | 366 | Q92753 | |
| TDGIFETFTIEIIDS | 1461 | P24821 | |
| EVVSFLTTAIESVDN | 551 | Q6N022 | |
| ELFQDSLVFDITVIT | 1216 | P08922 | |
| TVIFVSFQLSVATED | 3936 | Q86WI1 | |
| QTSILESERETITFF | 821 | Q6UXZ4 | |
| FSVDRIDVVVATTLS | 671 | Q00722 | |
| ASVSFQDVTVEFTRE | 6 | Q5TYW1 | |
| SDVLSSDAVAVTFAD | 296 | Q92536 | |
| VVAESVSSLTIADAF | 6 | Q92664 | |
| FDFTTTKALSEDSVV | 1091 | Q9Y4F4 | |
| SSINALATVTFEDFV | 351 | Q1EHB4 | |
| VLTFFDLDARVTDST | 566 | Q9P2L0 | |
| SVSFKDVTVDFTQEE | 6 | Q96SR6 | |
| SVLASVFLFVAETTA | 6 | P51811 | |
| IKTEFTLTEAVVESS | 181 | Q15554 | |
| VSVTFDDVAVTFTQE | 11 | Q5CZA5 | |
| TTILAEFATDDEVSR | 1711 | Q9UPQ9 | |
| FELVVFLDGTVESTS | 291 | P48048 | |
| IFITSVDAATTFEEL | 26 | Q05513 | |
| IFTFECDTIHVSESI | 531 | P57103 | |
| KITISTDAFEDTVTI | 486 | Q5VTT5 |